secwatch.observer — SEC 8-K summary
======================================

Issuer:     1606 CORP. (CBDW)
CIK:        0001877461
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0001477932-24-007384
Event type: other_material
Sentiment:  positive
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

1606 Corp. files Q3 10-Q, signs LOI with Adnexus Biotechnologies
----------------------------------------------------------------

- Filed Q3 10-Q for period ended September 30, 2024, maintaining continuous quarterly filings since inception.
- Signed Letter of Intent with Adnexus Biotechnologies for a potential strategic investment in AI and biotech.
- No financial metrics reported; press release focuses on narrative progress and forward-looking outlook.
- CEO plans to close Adnexus investment and expand AI chatbot solutions into healthcare, finance, and telecom.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/0001477932-24-007384-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/onesix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-007384

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer